Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
<p>Abstract</p> <p>Current interest in proteasome inhibitors for cancer therapy has stimulated considerable research efforts to identify the molecular pathway to their cytotoxicity with a view to identifying the mechanisms of sensitivity and resistance as well as informing the deve...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2011-10-01
|
| Series: | BMC Biology |
| Online Access: | http://www.biomedcentral.com/1741-7007/9/72 |